<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Dividend Increase on FinanClub</title>
    <link>https://finan.club/tags/dividend-increase/</link>
    <description>Recent content in Dividend Increase on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 11 Apr 2024 09:04:36 +0000</lastBuildDate><atom:link href="https://finan.club/tags/dividend-increase/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>AZN</title>
      <link>https://finan.club/us/azn/</link>
      <pubDate>Thu, 11 Apr 2024 09:04:36 +0000</pubDate>
      
      <guid>https://finan.club/us/azn/</guid>
      <description>score:-39
Chances: AstraZeneca plans to raise its annual dividend by 7% for 2024, showing potential for increased shareholder returns. Enhertu, co-developed by AstraZeneca, has been approved by the FDA for treating metastatic HER2+ solid tumors, indicating potential for revenue growth. AstraZeneca&amp;rsquo;s strong Buy rating and technological edge in biopharmaceuticals position it as an investable stock with impressive growth prospects.</description>
    </item>
    
  </channel>
</rss>
